Tiffany joined the BHL in May 2021 as a Master’s student in Pharmaceutical Sciences to work on the role of NOX2 as a new drug target in Alzheimer’s disease to repair blood-brain barrier dysfunction. Tiffany successfully defended and will graduate with a dual PharmD/MS degree on May 3. Congratulations, Tiffany!

Valerie featured in UKNow
UKNow featured Valerie and her participation in the Sanders-Brown Center on Aging NIH-funded Kentucky Alzheimer’s Disease Postbaccalaureate Research Education Program (KYAD-PREP). The program provided Valerie with mentored research experience in Alzheimer’s disease and related disorders before beginning her PhD training at UK. Read the full story in UKNow.

